ArticleBMC cardiovascular disorders2025
Four-dimensional echocardiographic quantification of left atrial function in metabolic syndrome across different diastolic function states.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Echocardiographic Assessment of Left Ventricular Diastolic Function in Adults Between Old and New: Progress and Challenges.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundMetabolic syndrome (MS), characterized by insulin resistance and systemic inflammation, is closely associated with increased cardiovascular morbidity. Although left atrial (LA) dysfunction is now recognized as an early indicator of cardiometabolic impairment, the progression of LA phasic functional changes across stages of diastolic dysfunction in MS remains poorly quantified. Emerging four-dimensional automatic LA quantification (4D-LAQ) enables more precise assessment of metabolism-induced cardiac remodeling. PURPOSE: To assess alterations in LA function among MS patients with different stages of diastolic dysfunction using 4D-LAQ.
methodsA total of 72 patients with MS and 34 healthy volunteers were included. MS patients were divided into three groups based on their diastolic function status. General clinical indicators and standard echocardiographic measurements were obtained. 4D-LAQ was used to quantify LA volume and strain parameters, which were then compared among the groups.
resultsLA volume parameters were significantly increased in all three MS groups compared to the control group, while LA strain parameters were reduced (p < 0.05). In the group with diastolic dysfunction, LA volume was further increased, and LA strain parameters as well as the LA emptying fraction (LAEF) were significantly lower than in the other groups (p < 0.05).
conclusion4D-LAQ allows reliable assessment of LA volume, strain, and functional changes in MS patients, particularly during left ventricular (LV) diastolic dysfunction. This approach may contribute to improved diagnosis, treatment planning, and clinical evaluation in patients with MS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.